Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology

Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):3-20. doi: 10.1016/j.reuma.2018.03.011. Epub 2018 May 4.
[Article in English, Spanish]

Abstract

There are national and international clinical practice guidelines for systemic lupus erythematosus treatment. Nonetheless, most of them are not designed for the Mexican population or are devoted only to the treatment of certain disease manifestations, like lupus nephritis, or are designed for some physiological state like pregnancy. The Mexican College of Rheumatology aimed to create clinical practice guidelines that included the majority of the manifestations of systemic lupus erythematosus, and also incorporated guidelines in controversial situations like vaccination and the perioperative period. The present document introduces the «Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus» proposed by the Mexican College of Rheumatology, which could be useful mostly for non-rheumatologist physicians who need to treat patients with systemic lupus erythematosus without having the appropriate training in the field of rheumatology. In these guidelines, the reader will find recommendations on the management of general, articular, kidney, cardiovascular, pulmonary, neurological, hematologic and gastrointestinal manifestations, and recommendations on vaccination and treatment management during the perioperative period.

Keywords: Guía de práctica clínica; Lupus eritematoso sistémico; Practice guidelines; Systemic lupus erythematosus; Tratamiento; Treatment.

Publication types

  • Practice Guideline

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / therapy*
  • Mexico

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents